Background {#s1}
==========

Metabolic disorder (MD) is a cluster of metabolic risk factors characterized by obesity, elevated blood pressure, increased plasma glucose (fasting), high triglycerides in serum and decreased high-density cholesterol levels \[[@R01]\]. Metabolic disorder affected people are at increased risk for atherosclerosis, peripheral vascular disease, coronary heart disease, myocardial infarction, stroke, and type 2 diabetes \[[@R02]-[@R05]\]. These are the leading causes of disability worldwide \[[@R06]\]. The consequences of metabolic disorders are often treated by healthy weight, diet and physical activities \[[@R07],[@R08]\]. So, evaluation of metabolic risk factors and the identification of population groups at risk of chronic diseases are essential for developing prevention strategies. Hence, the dynamic modeling of biological systems to describe various human diseases is of interest in recent years.

The complex network of proteins (gene products) and their biological processes mediating interactions among them in these diseases are of importance to understand. The application of protein interaction networks to available disease datasets in the public domain allows the identification of genes and their corresponding proteins. This helps the creation of sub-networks to study network properties for the classification of diseaseassociated genes in networks. It is found that several strategies have been employed to analyze gene networks using data for protein interactions in these conditions. However, this is a complex and a challenging task to pursue \[[@R09]\]. The information related to the disease mechanism gleaned using data for gene networks at a system level is critical yet it is highly convoluted. This is possible by collecting relevant data followed by cleaning such data by removing redundant information for useful yet specific knowledge establishments. This is helpful for improved data analysis followed by data integration to create a reliable model of the disease under study. Thus, gene network methods have been used to gain insights into disease mechanisms \[[@R10],[@R11]\], co-morbidity (anomalous conditions) \[[@R12],[@R13]\], protein target identification \[[@R14]-[@R16]\] and biomarker detection \[[@R17],[@R18]\]. The gene network based study includes elucidation of a complex system by fragmenting them into finite components (nodes or vertices) and interactions (edges). This conceptual illustration helps in the understanding of complex molecular disturbances in diseased conditions. Therefore, it is of interest to use graph theory based pathway diagrams using pertinent co-localization information with shared domain data between MD and ARD by mediating protein-protein interaction networks to identify the genes in a common pathway among disease types, states and conditions.

Methodology {#s2}
===========

Disease associated gene data collection from known literature {#s2a}
-------------------------------------------------------------

We gathered disease associated proteins (gene products) and or their corresponding genes related data from publically (WWW -- World Wide Web) available databases such as PubMed (http://www.ncbi.nlm.nih.gov/pubmed), PubMed Central (PMC - (http://www.ncbi.nlm.nih.gov/pmc) and other open access journals maintained by several publishers across Nations. This is done through disease specific manual keyword (metabolic disorder (MD), age related disorder (ARD), relevant genes) searching, article gathering, visual scanning, reading, studying, understating, cleaning, grouping, labeling, refining, storing in simple RDBMS, and subsequent data retrieval for value addition, information enrichment and knowledge creation on the subject of the study. It should be noted that PubMed and PMC are maintained at National Centre for Biotechnology (NCBI), National Institute of Health (NIH), USA.

Disease specific network creation {#s2b}
---------------------------------

We used GeneMANIA (http://www.genemania.org/) \[[@R19]\] to collect data related to metabolic disorder (MD) for relevant information gathering and knowledge establishment with available graphical network diagrams retrieved from the server in this study. GeneMANIA provides data for protein-protein interactions, protein-DNA interactions and or protein-gene interactions, corresponding pathways, associated reactions, available phenotypic profiles and genes expression data with corresponding known yet characterized proteins in the network. The data thus described is reasonably representative if not comprehensive.

Common pathway identification {#s2c}
-----------------------------

We used the pathway database (http://www. pathwaycommons.org) \[[@R20]\] to identify the common pathways amongst genes of metabolic disorder (MD). Pathway commons is a collection of pathway information from multiple organisms. A comprehensive collection of biological pathways from multiple sources is provided by pathway commons and represented in a common language for genes based metabolic pathway analysis.

Pathway analysis {#s2d}
----------------

We used Reactome (http://www.reactome.org/), a curated, peer reviewed and an open source pathway database for exploring the pathway knowledge for common genes \[[@R21]\].

Gene localization and domain analysis {#s2e}
-------------------------------------

Genes are often expressed in the same tissue and corresponding proteins can be found in the same location. Two or more genes are linked if they are expressed in the same tissue and their corresponding proteins are found in the same cellular location. Similarly, two proteins (gene products) are linked if they have the same defined (sequence and or structure) protein domain. This is completed using InterPro, SMART and Pfam facilities in the public domain. Gene localization and domain analysis are completed using the tools at GeneMANIA (http://www.gene mania.org/).

Results & Discussion {#s3}
====================

The hypothesis describing the mechanism leading the molecular disturbances in metabolic disorders (MD) and agerelated disorders (ARD) is usually non-trivial nature. Therefore, it is important to relate a disease condition with its know yet reasonably representative associated genes for the construction of its corresponding protein-protein interaction networks. It is also of critical importance to identify genes and or their protein products that share common pathways between different disease conditions (e.g. MD and ARD). Therefore, we used textmining (keyword searching) techniques to identify genes associated with MD as shown in [Figure 1](#F1){ref-type="fig"}. The text-mining analysis searched for respective known genes associated with 36 metabolic diseases ([Table 1](#T1){ref-type="table"}). Thus, genes known to be associated with each described metabolic disorder is listed.

The listed data were further analyzed to identify key genes associated with various diseases for network analysis and evaluation ([Figure 2](#F2){ref-type="fig"}). This exercise identified five common pathways with predicted genes for possible disease association from the network analysis ([Figure 3](#F3){ref-type="fig"}). Subsequently, common pathway genes with specific diseases are thus summarized ([Table 2](#T2){ref-type="table"}). This data shows that APOB, LDLR, APOE, LIPC genes are found in common pathways for lipid digestion, mobilization, and transport. Results show that two genes APOE, LIPC were not in MD but they shared the common pathway with APOB, LDLR responsible for Glycogen storage Disease type 0 (GSD). These two predicted genes are known to cause age-related macular degeneration (AMD) \[[@R22],[@R23]\]. The BCKDHA, DBT, DLD and BCKDHB genes were found in the pathways of branched-chain amino acid catabolism and metabolism of amino acids and its derivatives. However, the predicted DLD gene was known to be associated with skin photo aging \[[@R24]\]. The other three genes (BCKDHA, DBT, and BCKDHB) are the causative agent of MD described as Male Syrap Urine Disease (MSUD) as given in [Table 1](#T1){ref-type="table"}.

The four genes (PYGM, PHKB, PHKG1, PHKA1) were found in a common pathway from the network analysis sharing glycogenolysis (glycogen breakdown) and carbohydrate metabolism. The predicted gene PHKG1 is known to be associated with adenoid cystic carcinoma \[[@R25]\]. The other three genes PYGM, PHKB and PHKA1 involved in glycogen storage disease type 5 (GSDV) and glycogen storage disease type 9 (GSDIX) is also observed in the network analysis. The other set of genes (HEPH, CP and SLC40A1) were also found in common pathways of metal ion SLC transporters, iron uptake and transport, glucose transport, transport of bile salts and organic acids, metal ions and amine compounds, SLC-mediated transmembrane transport and trans-membrane transport of small molecules. It should be noted that HEPH and CP are not associated with MD but they are involved with age-related macular degeneration (AMD) \[[@R25]\].

Two genes (ABCC8 and KCNJ11) associated with Type 2 diabetes (Table 2) and aging share a common pathway and hence have a linkage \[[@R26]\]. ABCC8 and KCNJ11 shared the common pathways for ATP sensitive K+ channels, inwardly rectifying K+ channels, ABC-family proteins mediated transport, regulation of insulin secretion, integration of energy metabolism, neuronal system association, trans-membrane transport of small molecules and other metabolism as given in Table 2. Common genes associated with both MD and ARD are further processed for molecular interactions using network analysis as described in the methodology section. It is further showed that these genes shared the same domain in pathway regulation ([Figure 4](#F4){ref-type="fig"}). They are also co-localized with each other in tissues when expressed.

It is of important to understand the specific molecular pathways unique to a disease to elucidate the difference in these pathways. Therefore, it is essential to construct a 'linkage network' between diseases that are inter-linked by one or more genes found associated with the diseases using simplified network diagrams. We illustrated a linkage network based on pathway data, domain information and co-localization analyses between MD and ARD in this report. Thus, a model hypothesis is proposed using interaction networks that are linked between MD and ARD ([Figure 5](#F5){ref-type="fig"}).

Conclusion {#s4}
==========

We report data for common pathway of genes responsible for metabolic disorders (MD) and age related disorders (ARD). Data shows the linkage of genes in these diseases by analyzing their co-localization and shared domains. Pathway analysis with gene regulatory network evaluation using gene circuits and module design for further analysis of gene product interactions is essential for understanding the mechanism of the disease in relation to molecular cellular biology events.
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###### Description of common genes in pathways associated with specific diseases.

  Metabolic disorders                                                                                      Responsible genes
  ----------------------------------- -------------------------------------------------------------------- ---------------------------------
  Diabetes                            Type 1                                                               HLA DQA1, DQB1, DRB1
  Type 2                              TCF7L2, PPARG, KCNJ11, NOTCH2, WFS1, IGF2BP2, SLC30A8, JAZF1, HHEX   
  Phenyl-keto-nuria                                                                                        PAH
  Glucose galactose mal-absorption                                                                         SGLT1
  Tyrosine-mia                                                                                             FAH, HPD, TAT
  Alkaptonuria                                                                                             HGD
  Homo-cystinuria                                                                                          CBS, MTHFR, MTR, MTRR, MMADHC
  Maple syrup urine disease                                                                                BCKDHA, BCKDHB, DBT
  Propionic acid-emia                                                                                      PCCA, PCCB
  Methyl-malonic acid-emia                                                                                 MUT, MMAA, MMAB, MMADHC, MCEE
  Hyper-cholesterol-emia                                                                                   APOB, LDLR, LDLRAP1, PCSK9
  Glycogen storage disease            Type 0                                                               GYS1, GYS2
  Type 1                              G6PC, SLC37A4                                                        
  Type 2                              GAA (Pomp disease)                                                   
  Type 3                              AGL                                                                  
  Type 4                              GBE1                                                                 
  \>Type 5                            PYGM                                                                 
  Type 6                              PYGL                                                                 
  Type 7                              PFKM                                                                 
  Type 9                              PHKA1, PHKA2, PHKB, PHKG2                                            
  Type 10                             PGAM2 (Phospho-glycerate mutase deficiency)                          
  Galactose-mia                       GALE, GALK1, GALT                                                    
  Congenital glycosylation disorder   ALG12                                                                
  Type Ic                             ALG6                                                                 
  Type Iii                            COG5                                                                 
  Lesch-Nyhan syndrome                                                                                     HPRT1
  Gaucher disease                                                                                          GBA
  Tay-Sachs disease                                                                                        HEXA
  Fabry disease                                                                                            GLA
  Hurler syndrome                                                                                          IDUA
  Hunter syndrome                                                                                          IDS
  Sanfilippo syndrome                                                                                      GNS, HGSNAT, NAGLU, SGSH
  Maroteaux-Lamy syndrome                                                                                  ARSB
  Morquio syndrome                                                                                         GALNS, GLB1
  Refsum disease                                                                                           PEX7, PHYH
  Hemo-chromatosis                                                                                         HAMP, HFE, HFE2, SLC40A1, TFR28

###### Description of manually gleaned common pathway genes with known specific diseases.

ID = identifier; ATP = adenosine tri-phosphate; K+ = potassium; SLC = solute carrier; ABC = ATP-binding cassette; AMD = age-related macular degeneration; HC = Hemo-chromatosis; GSDV = Glycogen storage disease type 5; GSDIX = Glycogen storage disease type 9; MSUD = Maple Syrap Urine Disease; GSD = Glycogen storage disease type 0; SP = skin photo aging; glyco-genolysis = glycogen breakdown

  Genes                      Pathway ID R-HAS(prefix)                                                                   Pathways                                      Known disease genes   Common pathway (predicted)   Reference                                                
  -------------------------- ------------------------------------------------------------------------------------------ --------------------------------------------- --------------------- ---------------------------- --------------------- ------- -------------------------- ------------
  APOB; LDLR; APOE; LIPC     73923                                                                                      Lipid digestion, mobilization and transport   GSD                                                APOB                  APOE    AMD                        \[[@R22]\]
                                                                                                                                                                                            LDL                          LIPC                  AMD     \[[@R23]\]                 
  BCKDHA; DBT; DLD; BCKDHB   70895                                                                                      Branched chain amino acid catabolism          MSUD                                               BCKDHA; BCKDHB; DBT   DLD     SP                         \[[@R24]\]
  71291                      Metabolism of amino acids and its derivatives                                                                                                                                                                                                        
  PYGM; PHKB;PHKG1; PHKA1    70221                                                                                      Glyco-genolysis                               GSDV                                               PYGM                  PHKG1   Adenoid cystic carcinoma   \[[@R25]\]
  70326                      Carbohydrate metabolism                                                                    GSDIX                                                               PHKB; PHKA1                                                                           
  71387                                                                                                                                                                                                                                                                           
  1430728                                                                                                                                                                                                                                                                         
  HEPH;CP;SLC40A1            425410                                                                                     Metal ion SLC transporters                    HC                                                 SLC40A1               HEPH    AMD                        \[[@R26]\]
  917937                     Iron uptake and transport                                                                                                                                                                                                                            
  425366                     Transport of sugars (glucose), bile salts, organic acids, metal ions and amine compounds                                                                                                                                                             
  425407                     SLC-mediated trans-membrane transport                                                                                                                                                       CP                    AMD     \[[@R26]\]                 
  382551                     Trans-membrane transport of small molecules                                                                                                                                                                                                          
  ABCC8;KCNJ11               1296025                                                                                    ATP sensitive K+ channels                     Type 2 diabetes                                    KCNJ11                ABCC8   Ageing                     \[[@R27]\]
  1296065                    Inwardly rectifying K+ channels                                                                                                                                                                                                                      
  382556                     ABC proteins mediated transport                                                                                                                                                                                                                      
  422356                     Insulin secretion regulation                                                                                                                                                                                                                         
  1296071                    K+ channels                                                                                                                                                                                                                                          
  163685                     Energy metabolism                                                                                                                                                                                                                                    
  112316                     Neuronal system                                                                                                                                                                                                                                      
  382551                     Trans-membrane transport of small molecules                                                                                                                                                                                                          
  1430728                    Metabolism related                                                                                                                                                                                                                                   

![A schematic representation for the linkage hypothesis between MD and ARD is shown.](97320630012022F1){#F1}

![A network of genes associated with the metabolic disorder (MD) is illustrated in this diagram. It should be noted that genes that are already known to be associated with the disorder is shown in the figure. Black nodes indicate known MD genes and gray nodes indicate genes that are predicted to be associated with the disorder.](97320630012022F2){#F2}

![An illustration showing common pathways between MD and ARD is given. (A) Common pathways of MD with predicted disorder associated genes are shown. (B) Five common pathways between MD and predicted disorder genes are illustrated.](97320630012022F3){#F3}

![A network between co-localized and domain-sharing genes is shown. Black nodes indicate the common pathway of genes between MD and ARD.](97320630012022F4){#F4}

![Venn diagram showing MD (dark green) and ARD (dark blue) disorders, and common genes of MD (light green) and ARD (light blue) is shown. Set of common pathway of genes for MD (light green) and intersection (Ash) for set of common genes between MD (light green) and ARD (light blue), (MD) ∩ (ARD) = {APOE, LIPC, HEPH, CP, DLD, ABCC8} are shown.](97320630012022F5){#F5}
